Mira Pharmaceuticals Relocates HQ
Ticker: MIRA · Form: 8-K · Filed: May 6, 2025 · CIK: 1904286
| Field | Detail |
|---|---|
| Company | Mira Pharmaceuticals, Inc. (MIRA) |
| Form Type | 8-K |
| Filed Date | May 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, address-change
TL;DR
Mira Pharma moved its HQ to Miami. Formerly Mira1a Therapeutics.
AI Summary
Mira Pharmaceuticals, Inc. filed an 8-K on May 6, 2025, reporting an "Other Events" item. The filing indicates a change in the company's principal executive offices to 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131. The company was formerly known as Mira1a Therapeutics, Inc., with a name change effective January 12, 2022.
Why It Matters
A change in principal executive offices can signal operational shifts or strategic realignments within the company.
Risk Assessment
Risk Level: low — The filing reports a change in address, which is a routine administrative event with no immediate financial or operational risk indicated.
Key Players & Entities
- MIRA PHARMACEUTICALS, INC. (company) — Registrant
- Mira1a Therapeutics, Inc. (company) — Former company name
- May 6, 2025 (date) — Date of report
- January 12, 2022 (date) — Date of name change
- 1200 Brickell Avenue, Suite 1950 #1183 Miami, Florida 33131 (address) — New principal executive offices
FAQ
What is the new principal executive office address for Mira Pharmaceuticals, Inc.?
The new principal executive office address is 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131.
When was the report filed?
The report was filed on May 6, 2025.
What was Mira Pharmaceuticals, Inc. formerly known as?
Mira Pharmaceuticals, Inc. was formerly known as Mira1a Therapeutics, Inc.
When did the company's name change occur?
The date of the name change was January 12, 2022.
What is the SIC code for Mira Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code is 2834 for Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 6, 2025 regarding MIRA PHARMACEUTICALS, INC. (MIRA).